Skip to content
  • COVID-19 Information & Videos »
  • Find a Doctor »
open
x
  • For Patients
    • Why NeuroStar?
      • Safety & Tolerability
      • Precision
      • About Depression
    • About NeuroStar
      • How it Works
      • Is it Right for You?
      • Clinical Results
    • Patient Corner
    • Health Insurance
  • For Physicians
  • Neuronetics
NeuroStar Home Link
  • For Patients
  • For Physicians
  • Neuronetics
  • Why NeuroStar
  • About NeuroStar
  • Patient Corner
  • Insurance
  • Precision Matters
  • The Precise Choice
  • Efficacy and Results
  • Insurance
  • Be a TMS Leader
  • Solutions
  • Investors
  • Meet the Team
  • News
  • Careers
  • Contact Us
  • Global Sites
    • English
    • Deutsch
    • 日本語
    • 한국어
  • How it Works
  • Is it Right for You?
  • Clinical Results
  • Coding and Billing
  • Medical Coverage Policies
  • Health Insurance Coverage
  • Services
  • Resources
  • Neuronetics Board
  • Safety & Tolerability
  • Precision
  • About Depression
  • Overview
  • Stock Information
  • News & Events
  • Financial Information
  • Corporate Governance
  • Investor Resources
  • The Key Role in TMS
  • TMS Myth vs Fact
  • Unique Coil
  • TrakStar
  • MT Assist
  • Safety
  • Practice Setting
  • Qualified Candidates
  • Practice Support
  • Practice Success Program
  • Clinical Training
  • Field Services
  • Patient Education
  • Public Relations
  • Providers
  • Events and Exhibits
  • Outcomes Registry
  • Mechanism of Action
  • Physician & Patient Testimonials
  • Scientific Publications

ProgPsych_311.pdf

ProgPsych_311.pdf

Post navigation

ProgPsych_311.pdf

Indication
NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

NeuroStar TMS Therapy is only available by prescription. A doctor can help decide if NeuroStar TMS Therapy is right for you.

Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of NeuroStar TMS (<0.1% per patient).

NeuroStar TMS Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar TMS Therapy has not been studied in patients who have not received prior antidepressant treatment.
Safety and Prescribing Information »

Our Commitment
Neuronetics is committed to compliance with state and federal laws regarding interaction with healthcare providers.
Commitment to Compliance »

  • Patient Resources
    • Find a Doctor
    • Find Insurance
    • Patient Corner
    • About Depression
    • Depression Hope Center
  • NeuroStar TMS
    • Healthcare Providers
    • Neuronetics
    • Contact Us
    • In the News
    • Prescribing Information
  • International
    • English
    • Deutsch
    • 日本語
    • 한국어
  • Website
    • Site Map
    • Glossary
    • References
    • Privacy Policy
    • Terms & Conditions
  • Contact Us
    • 1-877-600-7555
    • Facebook
    • Twitter
    • Instagram
    • YouTube
    • LinkedIn

53-51237-000_G

Copyright @ 2021 Neuronetics. All Rights Reserved.